LG Chem Ltd

LG Chem has begun mass production and supply of its first semiconductor stripper to global OSAT leader Amkor Technology. The customized process materials reduce photoresist and residue removal time by approximately 50%, enhancing manufacturing efficiency for advanced semiconductor packaging. This marks LG Chem's entry into the semiconductor stripper market, leveraging expertise from its display stripper business. The company is expanding its semiconductor materials portfolio as part of a strategy to more than double its electronics materials business.

Artificial intelligence is fundamentally reshaping the foam insulation industry as manufacturers deploy advanced AI and machine learning systems to optimize production, reduce emissions, and accelerate innovation in customized materials. AI and ML systems are enabling unprecedented accuracy in developing customized grades of rigid foam insulation, reducing trial periods and minimizing costly R&D processes. The European Green Deal and Circular Economy Action Plan are driving significant AI investments in recycling technologies, with companies like BASF collaborating with Endress+Hauser and University of Bayreuth to develop AI-enhanced recycling solutions. Major players including Dow and Google have formed alliances to enhance circularity of hard-to-recycle plastics and foam insulation, while Covestro AG implements AI systems across polycarbonate and polyurethane production lines. Rising demand from electric vehicle manufacturers and high-performance battery producers is driving customized foam insulation requirements, with LG Chem deploying AI systems for advanced materials in battery thermal management applications.

LabGenius Therapeutics and LG Chem have entered a multi-year research collaboration, option and licensing agreement to develop a next-generation multispecific antibody targeting solid tumours. LabGenius will use its AI/ML-driven antibody discovery platform, EVA, to design and engineer the antibody, receiving an undisclosed upfront payment and potential early milestones. If LG Chem exercises its option, LabGenius could earn triple-digit million dollars in clinical, regulatory and commercial milestones plus royalties on net sales. LG Chem will fund all research and development activities under the collaboration.